Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page’s footer revision tag was updated to v3.5.5, signaling a minor page revision. This change typically reflects small content or formatting updates rather than alterations to study data.
    Difference
    0.0%
    Check dated 2026-06-05T09:54:12.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The locations section has been expanded to add new recruitment sites, bringing the total to 21 locations across multiple states. New sites include Virginia Mason Medical Center in Seattle, WA, along with several other participating centers.
    Difference
    1%
    Check dated 2026-05-22T09:17:07.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new NEJM publication citation for Daraxonrasib in previously treated advanced RAS-mutant pancreatic cancer has been added, and the page revision tag was updated from v3.5.3 to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-15T03:30:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2. This reflects a minor version update to the page.
    Difference
    0.0%
    Check dated 2026-04-30T17:20:27.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Footer revision label updated to Revision: v3.5.2. The previous Revision: v3.5.0 entry was removed.
    Difference
    0.0%
    Check dated 2026-04-16T11:05:12.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T19:44:29.000Z thumbnail image

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.